Global HPV Genetically Engineered Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 105

Published Date: 09 Mar 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global HPV Genetically Engineered Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global HPV Genetically Engineered Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global HPV Genetically Engineered Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global HPV Genetically Engineered Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global HPV Genetically Engineered Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global HPV Genetically Engineered Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for HPV Genetically Engineered Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global HPV Genetically Engineered Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck & Co., Inc., GSK, Walvax Biotechnology Co.,Ltd., Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. and Sanofi Pasteur, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
HPV Genetically Engineered Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Bivalent HPV Vaccine
Quadrivalent HPV Vaccine
9-valent HPV Vaccine

Market segment by Application
Male
Female

Major players covered
Merck & Co., Inc.
GSK
Walvax Biotechnology Co.,Ltd.
Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
Sanofi Pasteur
Serum Institute
Shanghai Zerun Biological Technology Co., Ltd.
Shanghai Bovax Biotechnology Co., Ltd.
Beijing Health Guard Biotechnology Inc.
Jiangsu Recbio Technology Co., Ltd.

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe HPV Genetically Engineered Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of HPV Genetically Engineered Vaccine, with price, sales, revenue and global market share of HPV Genetically Engineered Vaccine from 2018 to 2023.
Chapter 3, the HPV Genetically Engineered Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the HPV Genetically Engineered Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and HPV Genetically Engineered Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of HPV Genetically Engineered Vaccine.
Chapter 14 and 15, to describe HPV Genetically Engineered Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of HPV Genetically Engineered Vaccine
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global HPV Genetically Engineered Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Bivalent HPV Vaccine
        1.3.3 Quadrivalent HPV Vaccine
        1.3.4 9-valent HPV Vaccine
    1.4 Market Analysis by Application
        1.4.1 Overview: Global HPV Genetically Engineered Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Male
        1.4.3 Female
    1.5 Global HPV Genetically Engineered Vaccine Market Size & Forecast
        1.5.1 Global HPV Genetically Engineered Vaccine Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global HPV Genetically Engineered Vaccine Sales Quantity (2018-2029)
        1.5.3 Global HPV Genetically Engineered Vaccine Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Merck & Co., Inc.
        2.1.1 Merck & Co., Inc. Details
        2.1.2 Merck & Co., Inc. Major Business
        2.1.3 Merck & Co., Inc. HPV Genetically Engineered Vaccine Product and Services
        2.1.4 Merck & Co., Inc. HPV Genetically Engineered Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Merck & Co., Inc. Recent Developments/Updates
    2.2 GSK
        2.2.1 GSK Details
        2.2.2 GSK Major Business
        2.2.3 GSK HPV Genetically Engineered Vaccine Product and Services
        2.2.4 GSK HPV Genetically Engineered Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 GSK Recent Developments/Updates
    2.3 Walvax Biotechnology Co.,Ltd.
        2.3.1 Walvax Biotechnology Co.,Ltd. Details
        2.3.2 Walvax Biotechnology Co.,Ltd. Major Business
        2.3.3 Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Product and Services
        2.3.4 Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Walvax Biotechnology Co.,Ltd. Recent Developments/Updates
    2.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
        2.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Details
        2.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
        2.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Product and Services
        2.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
    2.5 Sanofi Pasteur
        2.5.1 Sanofi Pasteur Details
        2.5.2 Sanofi Pasteur Major Business
        2.5.3 Sanofi Pasteur HPV Genetically Engineered Vaccine Product and Services
        2.5.4 Sanofi Pasteur HPV Genetically Engineered Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Sanofi Pasteur Recent Developments/Updates
    2.6 Serum Institute
        2.6.1 Serum Institute Details
        2.6.2 Serum Institute Major Business
        2.6.3 Serum Institute HPV Genetically Engineered Vaccine Product and Services
        2.6.4 Serum Institute HPV Genetically Engineered Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Serum Institute Recent Developments/Updates
    2.7 Shanghai Zerun Biological Technology Co., Ltd.
        2.7.1 Shanghai Zerun Biological Technology Co., Ltd. Details
        2.7.2 Shanghai Zerun Biological Technology Co., Ltd. Major Business
        2.7.3 Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
        2.7.4 Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Shanghai Zerun Biological Technology Co., Ltd. Recent Developments/Updates
    2.8 Shanghai Bovax Biotechnology Co., Ltd.
        2.8.1 Shanghai Bovax Biotechnology Co., Ltd. Details
        2.8.2 Shanghai Bovax Biotechnology Co., Ltd. Major Business
        2.8.3 Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
        2.8.4 Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Shanghai Bovax Biotechnology Co., Ltd. Recent Developments/Updates
    2.9 Beijing Health Guard Biotechnology Inc.
        2.9.1 Beijing Health Guard Biotechnology Inc. Details
        2.9.2 Beijing Health Guard Biotechnology Inc. Major Business
        2.9.3 Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Product and Services
        2.9.4 Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Beijing Health Guard Biotechnology Inc. Recent Developments/Updates
    2.10 Jiangsu Recbio Technology Co., Ltd.
        2.10.1 Jiangsu Recbio Technology Co., Ltd. Details
        2.10.2 Jiangsu Recbio Technology Co., Ltd. Major Business
        2.10.3 Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
        2.10.4 Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Jiangsu Recbio Technology Co., Ltd. Recent Developments/Updates

3 Competitive Environment: HPV Genetically Engineered Vaccine by Manufacturer
    3.1 Global HPV Genetically Engineered Vaccine Sales Quantity by Manufacturer (2018-2023)
    3.2 Global HPV Genetically Engineered Vaccine Revenue by Manufacturer (2018-2023)
    3.3 Global HPV Genetically Engineered Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of HPV Genetically Engineered Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 HPV Genetically Engineered Vaccine Manufacturer Market Share in 2022
        3.4.2 Top 6 HPV Genetically Engineered Vaccine Manufacturer Market Share in 2022
    3.5 HPV Genetically Engineered Vaccine Market: Overall Company Footprint Analysis
        3.5.1 HPV Genetically Engineered Vaccine Market: Region Footprint
        3.5.2 HPV Genetically Engineered Vaccine Market: Company Product Type Footprint
        3.5.3 HPV Genetically Engineered Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global HPV Genetically Engineered Vaccine Market Size by Region
        4.1.1 Global HPV Genetically Engineered Vaccine Sales Quantity by Region (2018-2029)
        4.1.2 Global HPV Genetically Engineered Vaccine Consumption Value by Region (2018-2029)
        4.1.3 Global HPV Genetically Engineered Vaccine Average Price by Region (2018-2029)
    4.2 North America HPV Genetically Engineered Vaccine Consumption Value (2018-2029)
    4.3 Europe HPV Genetically Engineered Vaccine Consumption Value (2018-2029)
    4.4 Asia-Pacific HPV Genetically Engineered Vaccine Consumption Value (2018-2029)
    4.5 South America HPV Genetically Engineered Vaccine Consumption Value (2018-2029)
    4.6 Middle East and Africa HPV Genetically Engineered Vaccine Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global HPV Genetically Engineered Vaccine Sales Quantity by Type (2018-2029)
    5.2 Global HPV Genetically Engineered Vaccine Consumption Value by Type (2018-2029)
    5.3 Global HPV Genetically Engineered Vaccine Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global HPV Genetically Engineered Vaccine Sales Quantity by Application (2018-2029)
    6.2 Global HPV Genetically Engineered Vaccine Consumption Value by Application (2018-2029)
    6.3 Global HPV Genetically Engineered Vaccine Average Price by Application (2018-2029)

7 North America
    7.1 North America HPV Genetically Engineered Vaccine Sales Quantity by Type (2018-2029)
    7.2 North America HPV Genetically Engineered Vaccine Sales Quantity by Application (2018-2029)
    7.3 North America HPV Genetically Engineered Vaccine Market Size by Country
        7.3.1 North America HPV Genetically Engineered Vaccine Sales Quantity by Country (2018-2029)
        7.3.2 North America HPV Genetically Engineered Vaccine Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe HPV Genetically Engineered Vaccine Sales Quantity by Type (2018-2029)
    8.2 Europe HPV Genetically Engineered Vaccine Sales Quantity by Application (2018-2029)
    8.3 Europe HPV Genetically Engineered Vaccine Market Size by Country
        8.3.1 Europe HPV Genetically Engineered Vaccine Sales Quantity by Country (2018-2029)
        8.3.2 Europe HPV Genetically Engineered Vaccine Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific HPV Genetically Engineered Vaccine Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific HPV Genetically Engineered Vaccine Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific HPV Genetically Engineered Vaccine Market Size by Region
        9.3.1 Asia-Pacific HPV Genetically Engineered Vaccine Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific HPV Genetically Engineered Vaccine Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America HPV Genetically Engineered Vaccine Sales Quantity by Type (2018-2029)
    10.2 South America HPV Genetically Engineered Vaccine Sales Quantity by Application (2018-2029)
    10.3 South America HPV Genetically Engineered Vaccine Market Size by Country
        10.3.1 South America HPV Genetically Engineered Vaccine Sales Quantity by Country (2018-2029)
        10.3.2 South America HPV Genetically Engineered Vaccine Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa HPV Genetically Engineered Vaccine Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa HPV Genetically Engineered Vaccine Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa HPV Genetically Engineered Vaccine Market Size by Country
        11.3.1 Middle East & Africa HPV Genetically Engineered Vaccine Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa HPV Genetically Engineered Vaccine Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 HPV Genetically Engineered Vaccine Market Drivers
    12.2 HPV Genetically Engineered Vaccine Market Restraints
    12.3 HPV Genetically Engineered Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of HPV Genetically Engineered Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of HPV Genetically Engineered Vaccine
    13.3 HPV Genetically Engineered Vaccine Production Process
    13.4 HPV Genetically Engineered Vaccine Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 HPV Genetically Engineered Vaccine Typical Distributors
    14.3 HPV Genetically Engineered Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global HPV Genetically Engineered Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global HPV Genetically Engineered Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
    Table 4. Merck & Co., Inc. Major Business
    Table 5. Merck & Co., Inc. HPV Genetically Engineered Vaccine Product and Services
    Table 6. Merck & Co., Inc. HPV Genetically Engineered Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Merck & Co., Inc. Recent Developments/Updates
    Table 8. GSK Basic Information, Manufacturing Base and Competitors
    Table 9. GSK Major Business
    Table 10. GSK HPV Genetically Engineered Vaccine Product and Services
    Table 11. GSK HPV Genetically Engineered Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. GSK Recent Developments/Updates
    Table 13. Walvax Biotechnology Co.,Ltd. Basic Information, Manufacturing Base and Competitors
    Table 14. Walvax Biotechnology Co.,Ltd. Major Business
    Table 15. Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Product and Services
    Table 16. Walvax Biotechnology Co.,Ltd. HPV Genetically Engineered Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Walvax Biotechnology Co.,Ltd. Recent Developments/Updates
    Table 18. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Basic Information, Manufacturing Base and Competitors
    Table 19. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
    Table 20. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Product and Services
    Table 21. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. HPV Genetically Engineered Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
    Table 23. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
    Table 24. Sanofi Pasteur Major Business
    Table 25. Sanofi Pasteur HPV Genetically Engineered Vaccine Product and Services
    Table 26. Sanofi Pasteur HPV Genetically Engineered Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Sanofi Pasteur Recent Developments/Updates
    Table 28. Serum Institute Basic Information, Manufacturing Base and Competitors
    Table 29. Serum Institute Major Business
    Table 30. Serum Institute HPV Genetically Engineered Vaccine Product and Services
    Table 31. Serum Institute HPV Genetically Engineered Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Serum Institute Recent Developments/Updates
    Table 33. Shanghai Zerun Biological Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 34. Shanghai Zerun Biological Technology Co., Ltd. Major Business
    Table 35. Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
    Table 36. Shanghai Zerun Biological Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Shanghai Zerun Biological Technology Co., Ltd. Recent Developments/Updates
    Table 38. Shanghai Bovax Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 39. Shanghai Bovax Biotechnology Co., Ltd. Major Business
    Table 40. Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
    Table 41. Shanghai Bovax Biotechnology Co., Ltd. HPV Genetically Engineered Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Shanghai Bovax Biotechnology Co., Ltd. Recent Developments/Updates
    Table 43. Beijing Health Guard Biotechnology Inc. Basic Information, Manufacturing Base and Competitors
    Table 44. Beijing Health Guard Biotechnology Inc. Major Business
    Table 45. Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Product and Services
    Table 46. Beijing Health Guard Biotechnology Inc. HPV Genetically Engineered Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Beijing Health Guard Biotechnology Inc. Recent Developments/Updates
    Table 48. Jiangsu Recbio Technology Co., Ltd. Basic Information, Manufacturing Base and Competitors
    Table 49. Jiangsu Recbio Technology Co., Ltd. Major Business
    Table 50. Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Product and Services
    Table 51. Jiangsu Recbio Technology Co., Ltd. HPV Genetically Engineered Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Jiangsu Recbio Technology Co., Ltd. Recent Developments/Updates
    Table 53. Global HPV Genetically Engineered Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 54. Global HPV Genetically Engineered Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 55. Global HPV Genetically Engineered Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 56. Market Position of Manufacturers in HPV Genetically Engineered Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 57. Head Office and HPV Genetically Engineered Vaccine Production Site of Key Manufacturer
    Table 58. HPV Genetically Engineered Vaccine Market: Company Product Type Footprint
    Table 59. HPV Genetically Engineered Vaccine Market: Company Product Application Footprint
    Table 60. HPV Genetically Engineered Vaccine New Market Entrants and Barriers to Market Entry
    Table 61. HPV Genetically Engineered Vaccine Mergers, Acquisition, Agreements, and Collaborations
    Table 62. Global HPV Genetically Engineered Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 63. Global HPV Genetically Engineered Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 64. Global HPV Genetically Engineered Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 65. Global HPV Genetically Engineered Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 66. Global HPV Genetically Engineered Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 67. Global HPV Genetically Engineered Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 68. Global HPV Genetically Engineered Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 69. Global HPV Genetically Engineered Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 70. Global HPV Genetically Engineered Vaccine Consumption Value by Type (2018-2023) & (USD Million)
    Table 71. Global HPV Genetically Engineered Vaccine Consumption Value by Type (2024-2029) & (USD Million)
    Table 72. Global HPV Genetically Engineered Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 73. Global HPV Genetically Engineered Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 74. Global HPV Genetically Engineered Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 75. Global HPV Genetically Engineered Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 76. Global HPV Genetically Engineered Vaccine Consumption Value by Application (2018-2023) & (USD Million)
    Table 77. Global HPV Genetically Engineered Vaccine Consumption Value by Application (2024-2029) & (USD Million)
    Table 78. Global HPV Genetically Engineered Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 79. Global HPV Genetically Engineered Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 80. North America HPV Genetically Engineered Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 81. North America HPV Genetically Engineered Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 82. North America HPV Genetically Engineered Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 83. North America HPV Genetically Engineered Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 84. North America HPV Genetically Engineered Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 85. North America HPV Genetically Engineered Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 86. North America HPV Genetically Engineered Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 87. North America HPV Genetically Engineered Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 88. Europe HPV Genetically Engineered Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 89. Europe HPV Genetically Engineered Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 90. Europe HPV Genetically Engineered Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 91. Europe HPV Genetically Engineered Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 92. Europe HPV Genetically Engineered Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 93. Europe HPV Genetically Engineered Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 94. Europe HPV Genetically Engineered Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 95. Europe HPV Genetically Engineered Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 96. Asia-Pacific HPV Genetically Engineered Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 97. Asia-Pacific HPV Genetically Engineered Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 98. Asia-Pacific HPV Genetically Engineered Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 99. Asia-Pacific HPV Genetically Engineered Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 100. Asia-Pacific HPV Genetically Engineered Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 101. Asia-Pacific HPV Genetically Engineered Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 102. Asia-Pacific HPV Genetically Engineered Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 103. Asia-Pacific HPV Genetically Engineered Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 104. South America HPV Genetically Engineered Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 105. South America HPV Genetically Engineered Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 106. South America HPV Genetically Engineered Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 107. South America HPV Genetically Engineered Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 108. South America HPV Genetically Engineered Vaccine Sales Quantity by Country (2018-2023) & (K Units)
    Table 109. South America HPV Genetically Engineered Vaccine Sales Quantity by Country (2024-2029) & (K Units)
    Table 110. South America HPV Genetically Engineered Vaccine Consumption Value by Country (2018-2023) & (USD Million)
    Table 111. South America HPV Genetically Engineered Vaccine Consumption Value by Country (2024-2029) & (USD Million)
    Table 112. Middle East & Africa HPV Genetically Engineered Vaccine Sales Quantity by Type (2018-2023) & (K Units)
    Table 113. Middle East & Africa HPV Genetically Engineered Vaccine Sales Quantity by Type (2024-2029) & (K Units)
    Table 114. Middle East & Africa HPV Genetically Engineered Vaccine Sales Quantity by Application (2018-2023) & (K Units)
    Table 115. Middle East & Africa HPV Genetically Engineered Vaccine Sales Quantity by Application (2024-2029) & (K Units)
    Table 116. Middle East & Africa HPV Genetically Engineered Vaccine Sales Quantity by Region (2018-2023) & (K Units)
    Table 117. Middle East & Africa HPV Genetically Engineered Vaccine Sales Quantity by Region (2024-2029) & (K Units)
    Table 118. Middle East & Africa HPV Genetically Engineered Vaccine Consumption Value by Region (2018-2023) & (USD Million)
    Table 119. Middle East & Africa HPV Genetically Engineered Vaccine Consumption Value by Region (2024-2029) & (USD Million)
    Table 120. HPV Genetically Engineered Vaccine Raw Material
    Table 121. Key Manufacturers of HPV Genetically Engineered Vaccine Raw Materials
    Table 122. HPV Genetically Engineered Vaccine Typical Distributors
    Table 123. HPV Genetically Engineered Vaccine Typical Customers
List of Figures
    Figure 1. HPV Genetically Engineered Vaccine Picture
    Figure 2. Global HPV Genetically Engineered Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global HPV Genetically Engineered Vaccine Consumption Value Market Share by Type in 2022
    Figure 4. Bivalent HPV Vaccine Examples
    Figure 5. Quadrivalent HPV Vaccine Examples
    Figure 6. 9-valent HPV Vaccine Examples
    Figure 7. Global HPV Genetically Engineered Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global HPV Genetically Engineered Vaccine Consumption Value Market Share by Application in 2022
    Figure 9. Male Examples
    Figure 10. Female Examples
    Figure 11. Global HPV Genetically Engineered Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global HPV Genetically Engineered Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global HPV Genetically Engineered Vaccine Sales Quantity (2018-2029) & (K Units)
    Figure 14. Global HPV Genetically Engineered Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 15. Global HPV Genetically Engineered Vaccine Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global HPV Genetically Engineered Vaccine Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of HPV Genetically Engineered Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 HPV Genetically Engineered Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 HPV Genetically Engineered Vaccine Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global HPV Genetically Engineered Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global HPV Genetically Engineered Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America HPV Genetically Engineered Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe HPV Genetically Engineered Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific HPV Genetically Engineered Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America HPV Genetically Engineered Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa HPV Genetically Engineered Vaccine Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global HPV Genetically Engineered Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global HPV Genetically Engineered Vaccine Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global HPV Genetically Engineered Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 30. Global HPV Genetically Engineered Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global HPV Genetically Engineered Vaccine Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global HPV Genetically Engineered Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 33. North America HPV Genetically Engineered Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America HPV Genetically Engineered Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America HPV Genetically Engineered Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America HPV Genetically Engineered Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe HPV Genetically Engineered Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe HPV Genetically Engineered Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe HPV Genetically Engineered Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe HPV Genetically Engineered Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific HPV Genetically Engineered Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific HPV Genetically Engineered Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific HPV Genetically Engineered Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific HPV Genetically Engineered Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 53. China HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America HPV Genetically Engineered Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America HPV Genetically Engineered Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America HPV Genetically Engineered Vaccine Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America HPV Genetically Engineered Vaccine Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa HPV Genetically Engineered Vaccine Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa HPV Genetically Engineered Vaccine Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa HPV Genetically Engineered Vaccine Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa HPV Genetically Engineered Vaccine Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa HPV Genetically Engineered Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. HPV Genetically Engineered Vaccine Market Drivers
    Figure 74. HPV Genetically Engineered Vaccine Market Restraints
    Figure 75. HPV Genetically Engineered Vaccine Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of HPV Genetically Engineered Vaccine in 2022
    Figure 78. Manufacturing Process Analysis of HPV Genetically Engineered Vaccine
    Figure 79. HPV Genetically Engineered Vaccine Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global HPV Genetically Engineered Vaccine Supply, Demand and Key Producers, 2023-2029

Global HPV Genetically Engineered Vaccine Supply, Demand and Key Producers, 2023-2029

date 09 Mar 2023

date Medical Devices & Consumables

The global HPV Genetically Engineered Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global HPV Genetically Engineered Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global HPV Genetically Engineered Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 11 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global HPV Genetically Engineered Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global HPV Genetically Engineered Vaccine Supply, Demand and Key Producers, 2024-2030

Global HPV Genetically Engineered Vaccine Supply, Demand and Key Producers, 2024-2030

date 18 Feb 2024

date Medical Devices & Consumables

The global HPV Genetically Engineered Vaccine market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

HPV Genetically Engineered Vaccine

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>